Rajiv De Silva

2011 - Valeant Pharmaceuticals International

In 2011, Rajiv De Silva earned a total compensation of $3.1M as President and Chief Operating Officer, Specialty Pharmaceuticals at Valeant Pharmaceuticals International, a 4% increase compared to previous year.

Compensation breakdown

Bonus$500,000
Non-Equity Incentive Plan$756,563
Salary$750,000
Stock Awards$1,068,351
Other$32,552
Total$3,107,466

De Silva received $1.1M in stock awards, accounting for 34% of the total pay in 2011.

De Silva also received $500K in bonus, $756.6K in non-equity incentive plan, $750K in salary and $32.6K in other compensation.

Rankings

In 2011, Rajiv De Silva's compensation ranked 2,057th out of 10,747 executives tracked by ExecPay. In other words, De Silva earned more than 80.9% of executives.

ClassificationRankingPercentile
All
2,057
out of 10,747
81st
Division
Manufacturing
741
out of 3,958
81st
Major group
Chemicals And Allied Products
159
out of 1,031
85th
Industry group
Drugs
92
out of 779
88th
Industry
Pharmaceutical Preparations
78
out of 567
86th
Source: SEC filing on April 30, 2012.

De Silva's colleagues

We found six more compensation records of executives who worked with Rajiv De Silva at Valeant Pharmaceuticals International in 2011.

2011

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2011

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2011

Brian Stolz

Valeant Pharmaceuticals International

Executive Vice President of Administration and Chief Human Capital Officer

2011

Mark Durham

Valeant Pharmaceuticals International

Senior Vice President, Human Resources

2011

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2011

Philip Loberg

Valeant Pharmaceuticals International

Chief Financial Officer

News

You may also like